BACKGROUND: Cancer specialists require an understanding of survivors' needs to insure optimal delivery of care. Training programs currently focus on treatment, while survivorship care focuses on time after treatment. Cancer survivorship training represents an education paradigm shift. METHODS: The Cancer Survivorship Workshop was held at the James P. Wilmot Cancer Center of the University of Rochester in academic year 2011-2012, with six sessions held. Objectives included the following: learning about survivorship from patient, primary care physician, and oncologist perspectives using a curriculum based on survivorship literature; designing treatment summaries (TSs) and survivorship care plans (SCPs) for five malignancies (lung, breast, prostate, colon, and lymphoma); and establishing collaboration between hematology/oncology (HO) and radiation oncology (RO) trainees by working together in teams. Course impact was assessed pre- and post-training using a 13-question survey. Questions were answered using a 10-point scale, with predefined rating for each question. RESULTS: Statistically significant differences in responses to several survey questions were observed comparing pre- and post-course experience. Improvement was noted in comfort discussing survivorship issues with patients (p = 0.001), reported knowledge of survivorship care for five types of cancer (p = 0.002), confidence in ability to explain a SCP (p = 0.001), and comfort discussing late effects of cancer treatment (p = 0.001). Five unique sets of TS and SCPs were completed. CONCLUSIONS: This study demonstrates the feasibility of implementing cancer survivorship education into the curriculum of HO and RO training. IMPLICATIONS FOR CANCER SURVIVORS: The project was designed with intension to optimize survivor care through enhanced provider training.
BACKGROUND:Cancer specialists require an understanding of survivors' needs to insure optimal delivery of care. Training programs currently focus on treatment, while survivorship care focuses on time after treatment. Cancer survivorship training represents an education paradigm shift. METHODS: The Cancer Survivorship Workshop was held at the James P. Wilmot Cancer Center of the University of Rochester in academic year 2011-2012, with six sessions held. Objectives included the following: learning about survivorship from patient, primary care physician, and oncologist perspectives using a curriculum based on survivorship literature; designing treatment summaries (TSs) and survivorship care plans (SCPs) for five malignancies (lung, breast, prostate, colon, and lymphoma); and establishing collaboration between hematology/oncology (HO) and radiation oncology (RO) trainees by working together in teams. Course impact was assessed pre- and post-training using a 13-question survey. Questions were answered using a 10-point scale, with predefined rating for each question. RESULTS: Statistically significant differences in responses to several survey questions were observed comparing pre- and post-course experience. Improvement was noted in comfort discussing survivorship issues with patients (p = 0.001), reported knowledge of survivorship care for five types of cancer (p = 0.002), confidence in ability to explain a SCP (p = 0.001), and comfort discussing late effects of cancer treatment (p = 0.001). Five unique sets of TS and SCPs were completed. CONCLUSIONS: This study demonstrates the feasibility of implementing cancer survivorship education into the curriculum of HO and RO training. IMPLICATIONS FOR CANCER SURVIVORS: The project was designed with intension to optimize survivor care through enhanced provider training.
Authors: Sharon L Bober; Christopher J Recklitis; Eric G Campbell; Elyse R Park; Jean S Kutner; Julie S Najita; Lisa Diller Journal: Cancer Date: 2009-09-15 Impact factor: 6.860
Authors: Darcy A Reed; David A Cook; Thomas J Beckman; Rachel B Levine; David E Kern; Scott M Wright Journal: JAMA Date: 2007-09-05 Impact factor: 56.272
Authors: James L Khatcheressian; Antonio C Wolff; Thomas J Smith; Eva Grunfeld; Hyman B Muss; Victor G Vogel; Francine Halberg; Mark R Somerfield; Nancy E Davidson Journal: J Clin Oncol Date: 2006-10-10 Impact factor: 44.544
Authors: Christopher E Desch; Al B Benson; Mark R Somerfield; Patrick J Flynn; Carol Krause; Charles L Loprinzi; Bruce D Minsky; David G Pfister; Katherine S Virgo; Nicholas J Petrelli Journal: J Clin Oncol Date: 2005-10-31 Impact factor: 44.544
Authors: Wendy Landier; Smita Bhatia; Debra A Eshelman; Katherine J Forte; Teresa Sweeney; Allison L Hester; Joan Darling; F Daniel Armstrong; Julie Blatt; Louis S Constine; Carolyn R Freeman; Debra L Friedman; Daniel M Green; Neyssa Marina; Anna T Meadows; Joseph P Neglia; Kevin C Oeffinger; Leslie L Robison; Kathleen S Ruccione; Charles A Sklar; Melissa M Hudson Journal: J Clin Oncol Date: 2004-12-02 Impact factor: 44.544
Authors: Michael K Rooney; Fan Zhu; Erin F Gillespie; Jillian R Gunther; Ryan P McKillip; Matthew Lineberry; Ara Tekian; Daniel W Golden Journal: Int J Radiat Oncol Biol Phys Date: 2018-06-06 Impact factor: 7.038
Authors: Lindsay F Schwartz; Clarence H Braddock; Roy L Kao; Myung-Shin Sim; Jacqueline N Casillas Journal: J Cancer Surviv Date: 2018-06-25 Impact factor: 4.442
Authors: Nadine Linendoll; Rachel Murphy-Banks; Erin Barthel; Lisa Bartucca; Lauren Boehm; Madison Welch; Ruth Ann Weidner; Susan K Parsons Journal: J Adolesc Young Adult Oncol Date: 2020-07-08 Impact factor: 1.757